Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLenti CMV-SLC7A11-sh926R-FLAG-IRES-Hygro Citations (2)

Originally described in: Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.
Briggs KJ, Koivunen P, Cao S, Backus KM, Olenchock BA, Patel H, Zhang Q, Signoretti S, Gerfen GJ, Richardson AL, Witkiewicz AK, Cravatt BF, Clardy J, Kaelin WG Jr Cell. 2016 Jun 30;166(1):126-39. doi: 10.1016/j.cell.2016.05.042. PubMed Journal

Articles Citing pLenti CMV-SLC7A11-sh926R-FLAG-IRES-Hygro

Articles
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. Gao R, Kalathur RKR, Coto-Llerena M, Ercan C, Buechel D, Shuang S, Piscuoglio S, Dill MT, Camargo FD, Christofori G, Tang F. EMBO Mol Med. 2021 Dec 7;13(12):e14351. doi: 10.15252/emmm.202114351. Epub 2021 Oct 19. PubMed
CIC reduces xCT/SLC7A11 expression and glutamate release in glioma. Park JW, Kilic O, Deo M, Jimenez-Cowell K, Demirdizen E, Kim H, Turcan S. Acta Neuropathol Commun. 2023 Jan 16;11(1):13. doi: 10.1186/s40478-023-01507-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.